Data coverage, completeness and provenance for ALGORAE PHARMACEUTICALS LIMITED in the Stock Market API — Health Care · Biotechnology.
Source date: 2026-10-30T04:45:40. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.0100 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.0100 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.0095 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.0095 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.0090 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/1AI/prices · Price parameters and adjustment semantics
Algorae Pharmaceuticals Limited, an AI-enabled pharmaceutical development company, engages in the research and development of living cells technologies primarily in Australia and New Zealand. The company's product pipeline includes AI-116, a novel combination drug candidate made up of donepezil and cannabidiol for the treatment of dementia, including Alzheimer's disease; AI-168, a novel combination drug candidate made up of a cannabinoid and an off-patent pharmaceutical ingredient for the treatment of cardiovascular disease, such as hypertension; and NTCELL, an alginate coated capsule product for the treatment of Parkinson's disease. It is also developing AlgaraeOS in partnership with the University of New South Wales, a drug discovery platform that uses artificial intelligence protocols and big data analytics for drug discovery and development; and AlgoraeRx, a commercial pharmaceutical division that source generic and specialty medicines from manufacturers. The company was formerly known as Living Cell Technologies Limited and changed its name to Algorae Pharmaceuticals Limited in September 2023. Algorae Pharmaceuticals Limited was founded in 1987 and is based in Melbourne, Australia.
Website: https://algoraepharma.com · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/1AI/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (AUD) | 2026-06-30 | 22 | yfinance | ||||
| FY2024 (AUD) | 2024-06-30 | 20 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 21 | yfinance | ||||
| FY2022 (AUD) | 2022-06-30 | 21 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/1AI
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/1AI/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/1AI/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/1AI/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/1AI/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/1AI
Free tier — instant API key. Built for AI agents.